Charles Schwab Investment Management Inc Olema Pharmaceuticals, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 332,950 shares of OLMA stock, worth $2.04 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
332,950
Previous 330,761
0.66%
Holding current value
$2.04 Million
Previous $3.95 Million
50.85%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding OLMA
# of Institutions
145Shares Held
58.3MCall Options Held
141KPut Options Held
23.1K-
Bvf Inc San Francisco, CA9.14MShares$56 Million3.47% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5.5MShares$33.7 Million2.37% of portfolio
-
Deep Track Capital, LP Greenwich, CT4MShares$24.5 Million1.76% of portfolio
-
Black Rock Inc. New York, NY4MShares$24.5 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.69MShares$22.6 Million0.12% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $248M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...